Abstract
Sublethal doses of lucanthone (Miracil D) induced substantial mortality when administered to sublethally irradiated mice. Actinomycin D and lucanthone share many properties. Lucanthone's possible role as an adjuvant in clinical radiotherapy deserves consideration, especially in view of its wide use as a safe antiparasitic agent in man.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
